Drugs / Melanoma Reactive TIL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00314106 | Apr 2006 → Feb 2009 | metastatic melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melanoma Reactive TIL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00314106 ↗ |
| Modality | Cell therapy | “intravenous adoptive transfer of tumor reactive lymphocytes” NCT00314106 ↗ |
| Route | Intravenous | “patients receive the tumor-fighting cells by intravenous (IV) infusion” NCT00314106 ↗ |